Diagnostics

Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines

- Pursuing Divestiture of CertainT® Platform, Implements Changes to Corporate Leadership -- Build-out of GMP Manufacturing Facility to be Completed...

Quest Diagnostics Advances Environmental Stewardship With Renewable Energy Initiatives, Waste Reduction, and ISO 14001 Certifications in 2023

NORTHAMPTON, MA / ACCESSWIRE / December 17, 2024 / Quest DiagnosticsOriginally published in Quest Diagnostics' 2023 Corporate Responsibility ReportMinimizing our...

TruDiagnostic Introduces Revolutionary Epigenetic Biomarker Proxies: New Diagnostic Approach Outperforms Traditional Lab Results

LEXINGTON, Ky., Dec. 17, 2024 /PRNewswire/ -- TruDiagnostic, a global leader in advanced epigenetic research, proudly announces a groundbreaking advancement in...

Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Breast Cancer Patients with Leptomeningeal Metastases at the 2024 San Antonio Breast Cancer Symposium

Single intrathecal dose of Rhenium (186Re) Obisbemeda delivers favorable responses in cerebrospinal fluid circulating tumor cell count, imaging, and clinical...

Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out

Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests

CMS pricing determination marks a key milestone in gaining broad access to Medicare reimbursement.CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO),...

Lumicell Announces Poster Presentations at the 2024 San Antonio Breast Cancer Symposium Focused on Patient Benefit of Using LumiSystem™ During Lumpectomy

New data suggests that patients were satisfied with their cosmetic outcomes following the removal of suspicious tissue detected by fluorescence-guided...

IAVI and IPD Sign Agreement Formalizing Collaboration to Advance Vaccine Development, Manufacturing, and Access in Africa

Agreement signed to establish collaboration between IAVI and IPDNew partnership aims to accelerate vaccine development and manufacturing for priority pathogens...

error: Content is protected !!